Search - tctmd.com

Displaying 261 - 280 of 2071

Sort: Relevancy | Date

Presentation Miami Valves 2025

Heterotopic Cross-Caval Tricuspid Valve Replacement- New Innovations

Presenter: Santiago Garcia

January 30, 2025

Presentation Miami Valves 2025

FDA Approved Tricuspid Valve Replacement : What we know

Presenter: Pedro Villablanca

January 30, 2025

Presentation Controversies and Advances 2025

FDA Approval for TTVI

Presenter: David J. Cohen

January 30, 2025

News Opinion Editor's Corner

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Shelley Wood

January 01, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Todd Neale

December 19, 2024

News Conference News PCR London Valves 2024

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Michael O'Riordan

December 03, 2024

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

Presentation Cardiovascular Interventions 2024

Transcatheter Tricuspid Replacement or Repair: Matching the Device with the Patient

Presenter: Matthew J. Price

November 11, 2024

News Conference News TCT 2024

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Caitlin E. Cox

November 08, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

Patient Considerations

Presenter: Firas Zahr

October 30, 2024

Presentation TCT 2024

Imaging Considerations

Presenter: Rebecca Hahn

October 30, 2024

Presentation TCT 2024

Who to Treat With TTVI?

Presenter: Suzanne Arnold

October 30, 2024

Presentation TCT 2024

How to Manage After TTVI?

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Patient-Reported Outcomes are a True Measure of TTVI Value

Presenter: John Spertus

October 30, 2024

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Advertisement

Heterotopic Cross-Caval Tricuspid Valve Replacement- New Innovations

FDA Approved Tricuspid Valve Replacement : What we know

FDA Approval for TTVI

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Top Structural Heart News of 2024

December 2024 Dispatch for the CV Team

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Transcatheter Tricuspid Replacement or Repair: Matching the Device with the Patient

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Patient Considerations

Imaging Considerations

Who to Treat With TTVI?

How to Manage After TTVI?

Patient-Reported Outcomes are a True Measure of TTVI Value

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content